Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Sept 2026 for Coca-Cola HBC AG, €25k. Read the official filing
Filing timeline
BuySaleKaryn Harrighton
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Closed purchases
Market purchases
13
Positive at T+90
33%
Median T+90
-0.0%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -5.8%Entry £45.44 · Close 09 Oct 2026 £42.82
- -3.6%Entry £44.42 · Close 09 Oct 2026 £42.82
- -4.7%Entry £48.16 · Close at T+30 £45.92
- -13.8%Entry £49.70 · Close 09 Oct 2026 £42.82
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karyn Harrighton: trading record in brief
This profile gathers the share dealings of Karyn Harrighton in Coca-Cola HBC AG. In total, 13 filings cover trades dated from 17 April 2026 to 17 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -0.0%. These figures describe past trades and do not predict future prices.
The record was last updated on 19 September 2026 with a share grant (€25k) in Coca-Cola HBC AG. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Karyn Harrighton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
989.22 shares@ £21.2410.0001% mcap18.4% of flowXLONISIN CH0198251305RNS:9780295-10
Canonical exit: 16 Dec 2026 (T+90)
21.241 shares@ £46.57130.0000% mcap0.8% of flowXLONISIN CH0198251305FCA-NSM:960d7afd-62bb-4960-97fb-623cbb854d43-10
Canonical exit: 16 Dec 2026 (T+90)
912.27 shares@ £20.0370.0001% mcap16.0% of flowXLONISIN CH0198251305RNS:9728222-11
Canonical exit: 15 Nov 2026 (T+90)
20.037 shares@ £45.52930.0000% mcap0.8% of flowXLONISIN CH0198251305FCA-NSM:a56dbc51-4cd1-4d4d-9192-e2095a1dd404-11
Canonical exit: 15 Nov 2026 (T+90)
915.1 shares@ £18.4330.0001% mcap14.9% of flowXLONISIN CH0198251305RNS:9678059-11
Canonical exit: 15 Oct 2026 (T+90)
18.433 shares@ £49.64470.0000% mcap0.8% of flowXLONISIN CH0198251305FCA-NSM:42e3aacf-a69b-40c3-ad73-57773f9de9e7-11
Canonical exit: 15 Oct 2026 (T+90)
945.18 shares@ £20.5860.0001% mcap16.9% of flowXLONISIN CH0198251305RNS:9626124-11
Canonical exit: 15 Sept 2026 (T+90)
0XLONRNS:c429fc9a-8344-4620-bfca-ad06273394fc-11
Canonical exit: 15 Sept 2026 (T+90)
102.19 shares@ £228.300220.3% of flowXLONISIN CH0198251305RNS:9619208-3
Canonical exit: 9 Sept 2026 (T+90)
0XLONRNS:9f0bc752-7a6b-44e3-99d8-0fff20d2763f-3
Canonical exit: 9 Sept 2026 (T+90)
928.1 shares@ £16.855213.5% of flowXLONISIN CH0198251305RNS:9576123-11
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:cfd77d8b-474a-4838-9d16-8d9b51a277e7-11
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:e4673e71-fc27-4c38-a628-cfae4bc8b9f0-11
Canonical exit: 16 Jul 2026 (T+90)
13 of 13 declarations
